Financials
- Market Capitalization 1.55 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
—
市销率
4.65
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2145 | FBRX Forte Biosciences, Inc. - Common Stock | 76.99 USD | 0.00% | +0.06% | +0.59% | +162.32% | 1.63 B USD | ||
| 2170 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.43 USD | -5.64% | -1.22% | -10.20% | +62.26% | 1.55 B USD | ||
| 2175 | LBRX LB Pharmaceuticals Inc - Common Stock | 47.73 USD | -0.33% | -0.31% | +21.54% | +151.21% | 1.54 B USD | ||
| 2179 | NVAX Novavax, Inc. - Common Stock | 9.26 USD | +2.32% | +4.28% | +24.63% | +25.30% | 1.53 B USD |